Daxor Corp (DXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DXR | DGX | DVA | EHC | CHE |
| Company | Daxor Corp | Quest Diagnostics Inc | Davita Healthcare Partners Inc | Encompass Health Corp | Chemed Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 9.67 | 137.55 | 132.57 | 85.25 | 593.36 |
| High | 9.94 | 138.61 | 133.18 | 85.84 | 593.36 |
| Low | 9.61 | 134.13 | 131.34 | 81.45 | 561.00 |
| Last | 9.65 | 135.42 | 132.77 | 82.73 | 573.34 |
| Change | -0.29 | -2.13 | +0.03 | -0.07 | -44.61 |
| % Change | -2.92% | -1.55% | +0.02% | -0.08% | -7.22% |
| Volume | 1,800 | 1,016,000 | 519,200 | 1,488,200 | 260,700 |
| 20-Day Average Volume | 2,880 | 1,086,900 | 508,495 | 849,800 | 71,905 |
| Previous Close | 9.94 | 137.55 | 132.74 | 82.80 | 617.95 |
| Industry | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.44 | 131.24 | 132.39 | 81.44 | 617.95 |
| 20-Day Raw Stochastic | 81.23% | 74.13% | 56.54% | 57.46% | 14.40% |
| 20-Day Relative Strength | 58.25% | 59.03% | 54.45% | 61.99% | 32.62% |
| Weighted Alpha | -7.41 | +0.20 | +52.78 | +34.68 | +3.38 |
| Today's Opinion | 56% Buy | 40% Buy | 88% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 56% Buy | 24% Buy | 88% Buy | 100% Buy | 40% Buy |
| Last Month's Opinion | 48% Sell | 72% Sell | 100% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.92% since 04/18/24 | +7.55% since 04/18/24 | +5.28% since 04/18/24 | +5.23% since 04/18/24 | -4.03% since 04/18/24 |
| Low | 9.55 on 04/23/24 | 126.08 on 04/19/24 | 125.97 on 04/19/24 | 78.65 on 04/19/24 | 561.00 on 04/25/24 |
| High | 9.94 on 04/25/24 | 138.91 on 04/23/24 | 135.71 on 04/23/24 | 85.84 on 04/25/24 | 622.33 on 04/24/24 |
| 1-Month | |||||
| %Chg | +8.79% since 03/25/24 | +4.75% since 03/25/24 | -1.48% since 03/25/24 | +8.66% since 03/25/24 | -11.08% since 03/25/24 |
| Low | 8.11 on 03/27/24 | 125.42 on 04/18/24 | 125.64 on 04/18/24 | 76.11 on 03/26/24 | 561.00 on 04/25/24 |
| High | 9.94 on 04/25/24 | 138.91 on 04/23/24 | 138.25 on 04/01/24 | 85.84 on 04/25/24 | 646.71 on 03/28/24 |
| 3-Month | |||||
| %Chg | +7.22% since 01/25/24 | +4.05% since 01/25/24 | +23.59% since 01/25/24 | +16.21% since 01/25/24 | -3.46% since 01/25/24 |
| Low | 7.19 on 03/05/24 | 123.04 on 02/01/24 | 105.82 on 01/29/24 | 70.74 on 01/29/24 | 561.00 on 04/25/24 |
| High | 9.94 on 04/25/24 | 138.91 on 04/23/24 | 141.54 on 03/13/24 | 85.84 on 04/25/24 | 654.62 on 03/15/24 |
| 6-Month | |||||
| %Chg | +13.25% since 10/25/23 | +7.93% since 10/25/23 | +68.92% since 10/25/23 | +33.37% since 10/25/23 | +13.08% since 10/25/23 |
| Low | 7.11 on 11/29/23 | 123.04 on 02/01/24 | 75.47 on 10/30/23 | 57.55 on 10/27/23 | 516.03 on 10/26/23 |
| High | 10.04 on 01/04/24 | 143.63 on 01/02/24 | 141.54 on 03/13/24 | 85.84 on 04/25/24 | 654.62 on 03/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 47,065 | 15,275,752 | 11,641,298 | 8,291,592 | 9,341,544 |
| Shares Outstanding, K | 4,735 | 111,056 | 87,700 | 100,140 | 15,117 |
| Annual Sales | 1,450,000 | 9,252,000,000 | 12,140,150,000 | 4,801,200,000 | 2,264,420,000 |
| Annual Net Income | -7,190,000 | 854,000,000 | 691,540,000 | 352,000,000 | 272,510,000 |
| Last Quarter Sales | 342,584 | 2,288,000,000 | 3,145,750,000 | 1,246,800,000 | 585,910,000 |
| Last Quarter Net Income | -1,491,188 | 192,000,000 | 150,670,000 | 87,600,000 | 90,050,000 |
| 60-Month Beta | -0.46 | 0.91 | 1.04 | 0.94 | 0.42 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.04 on 04/23/24 | 1.87 on 02/13/24 | 1.12 on 04/24/24 | 5.20 on 04/24/24 |
| Latest Earnings Date | 03/25/24 | 04/23/24 | 05/02/24 | 04/24/24 | 04/24/24 |
| Most Recent Dividend | 0.030 on 01/05/18 | 0.710 on 01/16/24 | N/A | 0.150 on 03/28/24 | 0.400 on 02/23/24 |
| Next Ex-Dividends Date | 01/05/18 | 01/16/24 | N/A | 03/28/24 | 02/23/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.69 | 15.98 | 22.65 | 29.33 |